Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Fact or Myth? Aspirin for Primary Prevention


This program aims to help pharmacists maintain and enhance professional competencies to fulfill the following goals: 
- Ensure correct decision making in those patient populations in which aspirin for primary prevention is not recommended
- Satisfy education requirements for pharmacist re-licensure

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
 
Shenandoah University Bernard J. Dunn School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Requirements for CE Credit

To receive credit the following items must be completed

 
1. Register for the event through supharmacy.learningexpressce.com
2. Attend the entire activity
3. Complete all relevant learning assessments
4. Complete an activity evaluation through supharmacy.learningexpressce.com 

Support/Credits

No external funding has been obtained for this activity. The speakers have no conflicts of interest to disclose.

 

 

 

Objectives

  • Understand the mechanism of action of aspirin in primary prevention
  • Understand the mechanism of bleeding risk associated with aspirin
  • Discuss the ASCEND, ARRIVE, and ASPREE trials and their findings
  • Recognize the patient populations in which aspirin for primary prevention is not recommended

Speaker(s)/Author(s)

Kelly Gray, PharmD
PGY-1 Resident, Valley Health

Activity Number

0101-0000-20-002-H01-P

Release Date: May 20, 2020
Credit Expiration Date: May 20, 2023

CE Hours

1.00

Location

Valley Health